Catherine Wood's GH Position Overview
Catherine Wood (via Ark Investment Management LLC) currently holds 795.2K shares of Guardant Health, Inc. (GH) worth $49.69 M, representing 0.30% of the portfolio. First purchased in 2019-Q2, this long-term strategic position has been held for 26 quarters.
Based on 13F filings, Catherine Wood has maintained a strategic position in GH, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2025, adding 1.4M shares. Largest reduction occurred in Q3 2025, reducing 2.0M shares.
Analysis based on 13F filings available since 2013 Q2
Catherine Wood's Guardant Health (GH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Guardant Health (GH) Trades by Catherine Wood
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2019 | +74,041 | New Buy | 74,041 | $86.33 |
| Q3 2019 | +162 | Add 0.22% | 74,203 | $63.82 |
| Q4 2019 | +77,604 | Add 104.58% | 151,807 | $78.14 |
| Q1 2020 | +95,844 | Add 63.14% | 247,651 | $69.60 |
| Q2 2020 | +210,901 | Add 85.16% | 458,552 | $81.13 |
| Q3 2020 | -224,531 | Reduce 48.97% | 234,021 | $111.78 |
| Q4 2020 | +306,516 | Add 130.98% | 540,537 | $128.88 |
| Q1 2021 | +162,713 | Add 30.10% | 703,250 | $152.65 |
| Q2 2021 | -703,157 | Reduce 99.99% | 93 | $129.03 |
| Q4 2021 | -11 | Reduce 11.83% | 82 | $97.56 |
| Q1 2022 | -82 | Sold Out | 82 | $0.00 |
| Q3 2022 | +542,113 | New Buy | 542,113 | $53.83 |
| Q4 2022 | -42,007 | Reduce 7.75% | 500,106 | $27.20 |
| Q1 2023 | +83,149 | Add 16.63% | 583,255 | $23.44 |
| Q2 2023 | -8,260 | Reduce 1.42% | 574,995 | $35.80 |
| Q3 2023 | -1,672 | Reduce 0.29% | 573,323 | $29.64 |
| Q4 2023 | -135,223 | Reduce 23.59% | 438,100 | $27.05 |
| Q1 2024 | -76,934 | Reduce 17.56% | 361,166 | $20.63 |
| Q2 2024 | +92,424 | Add 25.59% | 453,590 | $28.88 |
| Q3 2024 | +1.06 M | Add 233.49% | 1.51 M | $22.94 |
| Q4 2024 | -72,842 | Reduce 4.82% | 1.44 M | $30.55 |
| Q1 2025 | -30,736 | Reduce 2.13% | 1.41 M | $42.60 |
| Q2 2025 | +1.41 M | Add 100.37% | 2.82 M | $52.04 |
| Q3 2025 | -2.03 M | Reduce 71.84% | 795,234 | $62.48 |
Catherine Wood's Guardant Health Investment FAQs
Catherine Wood first purchased Guardant Health, Inc. (GH) in Q2 2019, acquiring 74,041 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood has held Guardant Health, Inc. (GH) for 26 quarters since Q2 2019. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood's largest addition to Guardant Health, Inc. (GH) was in Q2 2025, adding 2,823,497 shares worth $146.93 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Catherine Wood's firm, Ark Investment Management LLC, owns 795,234 shares of Guardant Health, Inc. (GH), valued at approximately $49.69 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Guardant Health, Inc. (GH) represents approximately 0.30% of Catherine Wood's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood's peak holding in Guardant Health, Inc. (GH) was 2,823,497 shares, as reported at the end of Q2 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.